AGN-190584
ApprovedWithdrawn 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Presbyopia
Conditions
Presbyopia
Trial Timeline
Dec 1, 2022 → Jun 30, 2023
NCT ID
NCT05624320About AGN-190584
AGN-190584 is a approved stage product being developed by AbbVie for Presbyopia. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT05624320. Target conditions include Presbyopia.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05624320 | Approved | Withdrawn |
Competing Products
14 competing products in Presbyopia